Cargando…

Discovery of novel α-amylase inhibitors using structure-based drug design

Detalles Bibliográficos
Autores principales:	Al-Asri, Jamil, Wolber, Gerhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980051/ http://dx.doi.org/10.1186/1758-2946-6-S1-P50

Ejemplares similares

Discovery of novel TLR modulators by Molecular Modeling and Virtual Screening
por: Murgueitio, Manuela S, et al.
Publicado: (2012)

Ligand-side tautomer enumeration and scoring for structure-based drug-design
por: Seidel, Thomas, et al.
Publicado: (2010)

Genetically modified α-amylase inhibitor peas are not specifically allergenic in mice
por: Reiner, D, et al.
Publicado: (2013)

Using structure- and Ligand-based pharmacophores as filters to discriminate Human Aryl Sulfotransferase 1A1 (SUL1A1) binders into substrates and inhibitors
por: Soliman, Salwa M, et al.
Publicado: (2014)

Efficient 3D pharmacophore alignment as a tool for structure-based modeling and scoring
por: Wolber, Gerhard
Publicado: (2008)

Ligand-based and structure-based design of novel histone demethylase inhibitors
por: Carlino, Luca, et al.
Publicado: (2013)

Tautomerism in structure-based 3D pharmacophore modeling
por: Seidel, Thomas, et al.
Publicado: (2008)

Dualsteric modulators of the M2 muscarinic acetylcholine receptor
por: Bermudez, Marcel, et al.
Publicado: (2014)

Design and evaluation of chalconeimine derivatives as α-amylase inhibitors
por: Balu, Prithivirajan, et al.
Publicado: (2019)

Pharmacophore-based discovery of a novel cytosolic phospholipase A(2)α inhibitor
por: Noha, Stefan M., et al.
Publicado: (2012)

Computer-guided discovery of epigenetics drugs: molecular modeling and identification of inhibitors of DNMT1
por: Yoo, Jakyung, et al.
Publicado: (2012)

Computational discovery and experimental validation of novel drug targets in immuno-oncology
por: Levy, Ofer, et al.
Publicado: (2015)

Evaluation of molecular model-based discovery of ecto-5’-nucleotidase inhibitors on the basis of X-ray structures
por: Furtmann, Norbert, et al.
Publicado: (2014)

Discovery Potent of Thiazolidinedione Derivatives as Antioxidant, α-Amylase Inhibitor, and Antidiabetic Agent
por: Sameeh, Manal Y., et al.
Publicado: (2021)

Molecular docking analysis of novel Non-Nucleoside Reverse Transcriptase Inhibitors in development: implication for rational drug design
por: Singh, Udaya Pratap, et al.
Publicado: (2011)

Drug screening of α‐amylase inhibitors as candidates for treating diabetes
por: Alp, Meryem, et al.
Publicado: (2023)

Virtual screening and in silico design of novel inhibitors of bacterial lectins
por: Alán, Jan, et al.
Publicado: (2012)

The relative sensitivity of serum lipase versus amylase for radiological image-positive pancreatitis
por: Delaney, K, et al.
Publicado: (2007)

The Malaria Box: a catalyst for drug discovery
por: Burrows, Jeremy, et al.
Publicado: (2012)

Maximum-score diversity selection for early drug discovery
por: Meinl, Thorsten, et al.
Publicado: (2010)

PA02.11. An insight on ayurvedic drug discovery
por: Desai, Yogesh
Publicado: (2013)

Inhibition of Sunn Pest, Eurygaster integriceps, α-Amylases by α-Amylase Inhibitors (T-αAI) from Triticale
por: Mehrabadi, Mohammad, et al.
Publicado: (2010)

Synergistic approach of structure-based and ligand-based drug design for the development of selective cannabinod receptor ligands
por: Günther, Robert, et al.
Publicado: (2012)

Discovery of Novel Coumarin Derivatives as Potential Dual Inhibitors against α-Glucosidase and α-Amylase for the Management of Post-Prandial Hyperglycemia via Molecular Modelling Approaches
por: Patil, Shashank M., et al.
Publicado: (2022)

From biochemical and structural studies of soluble guanylate cyclase toward drug design
por: Laffly, Emmanuelle, et al.
Publicado: (2009)

Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
por: Telang, Sucheta, et al.
Publicado: (2014)

Response of pediatric uveitis to TNFα inhibitors
por: Lerman, Melissa A, et al.
Publicado: (2012)

Genetically Modified α-Amylase Inhibitor Peas Are Not Specifically Allergenic in Mice
por: Lee, Rui-Yun, et al.
Publicado: (2013)

Natural Inhibitors of Mammalian α-Amylases as Promising Drugs for the Treatment of Metabolic Diseases
por: Kalinovskii, Aleksandr P., et al.
Publicado: (2023)

http://Mcule.com: a public web service for drug discovery
por: Kiss, Robert, et al.
Publicado: (2012)

Strategies to improve lung absorption of intratracheally administered compounds in Drug Discovery
por: Calama, Elena, et al.
Publicado: (2013)

Understanding the pathophysiology of NOMID arthropathy for drug discovery by iPSCs technology
por: Nakagawa, K, et al.
Publicado: (2015)

Momilactones A and B Are α-Amylase and α-Glucosidase Inhibitors
por: Quan, Nguyen Van, et al.
Publicado: (2019)

Dietary Polyphenols as Natural Inhibitors of α-Amylase and α-Glucosidase
por: Ćorković, Ina, et al.
Publicado: (2022)

Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics
por: Shahzad, Danish, et al.
Publicado: (2019)

In silico virtual screening approaches for anti-viral drug discovery
por: Murgueitio, Manuela S., et al.
Publicado: (2012)

New approach to chemical biology for drug discovery: construction of new affinity beads and their application
por: Handa, H
Publicado: (2003)

Design, Synthesis, In Silico Testing, and In Vitro Evaluation of Thiazolidinone-Based Benzothiazole Derivatives as Inhibitors of α-Amylase and α-Glucosidase
por: Khan, Shoaib, et al.
Publicado: (2022)

Novel MDR-reversing inhibitors of MRP subtypes related to antiretroviral drug resistance and CD4 cell counts
por: Hilgeroth, Andreas, et al.
Publicado: (2014)

Close relationship of a novel Flavobacteriaceae α-amylase with archaeal α-amylases and good potentials for industrial applications
por: Li, Chunfang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q106na5s9jk4d574s4tkme2jek